WallStSmart

Uipath Inc (PATH)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Uipath Inc generates 29024% more annual revenue ($1.72B vs $5.91M). PATH leads profitability with a 21.0% profit margin vs 0.0%. PATH earns a higher WallStSmart Score of 70/100 (B-).

PATH

Strong Buy

70

out of 100

Grade: B-

Growth: 8.0Profit: 6.5Value: 7.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.50

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for PATH.

VUZIUndervalued (+36.7%)

Margin of Safety

+36.7%

Fair Value

$3.90

Current Price

$2.96

$0.94 discount

UndervaluedFair: $3.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PATH4 strengths · Avg: 9.8/10
PEG RatioValuation
0.4910/10

Growing faster than its price suggests

EPS GrowthGrowth
2281.0%10/10

Earnings expanding 2281.0% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Profit MarginProfitability
21.0%9/10

Keeps 21 of every $100 in revenue as profit

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Areas to Watch

PATH1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
10.2x4/10

Trading at 10.2x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$232.14M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : PATH

The strongest argument for PATH centers on PEG Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 21.0% and operating margin at 8.9%. Revenue growth of 13.4% demonstrates continued momentum.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : PATH

The primary concerns for PATH are Altman Z-Score.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

PATH profiles as a mature stock while VUZI is a value play — different risk/reward profiles.

VUZI carries more volatility with a beta of 1.82 — expect wider price swings.

PATH is growing revenue faster at 13.4% — sustainability is the question.

PATH generates stronger free cash flow (29M), providing more financial flexibility.

Bottom Line

PATH scores higher overall (70/100 vs 16/100), backed by strong 21.0% margins and 13.4% revenue growth. VUZI offers better value entry with a 36.7% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Uipath Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

UiPath Inc. provides an end-to-end automation platform offering a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company is headquartered in New York, New York.

Visit Website →

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?